{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:42:07Z","timestamp":1792395727384,"version":"4.4.0"},"reference-count":39,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.3201\/eid2206.151037","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T13:08:15Z","timestamp":1462194495000},"page":"949-955","source":"Crossref","is-referenced-by-count":51,"title":["Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza"],"prefix":"10.3201","volume":"22","author":[{"given":"Aeron C.","family":"Hurt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2206.151037-201605091329-R1","unstructured":"Goldacre B. What the Tamiflu saga tells us about drug trials and big pharma. The Guardian. April 10, 2014."},{"key":"key-10.3201\/eid2206.151037-201605091329-R2","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","article-title":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.","volume":"385","author":"Dobson","year":"2015","journal-title":"Lancet"},{"key":"key-10.3201\/eid2206.151037-201605091329-R3","first-page":"CD008965","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.","volume":"4","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.3201\/eid2206.151037-201605091329-R4","doi-asserted-by":"crossref","unstructured":"Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al MA, Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2:395\u2013404.","DOI":"10.1016\/S2213-2600(14)70041-4"},{"key":"key-10.3201\/eid2206.151037-201605091329-R5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nature02746","article-title":"Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.","volume":"430","author":"Li","year":"2004","journal-title":"Nature"},{"key":"key-10.3201\/eid2206.151037-201605091329-R6","unstructured":"Roche introduces program to facilitate corporate pandemic stockpiling of Tamiflu. PR Newswire, June 26, 2008 [cited 2015 Mar 30]. http:\/\/www.prnewswire.com\/news-releases\/roche-introduces-program-to-facilitate-corporate-pandemic-stockpiling-of-tamiflur-57551412.html"},{"key":"key-10.3201\/eid2206.151037-201605091329-R7","unstructured":"US Government Accounting Office. HHS spent nearly a quarter of the funds (about $1.30 billion) on activities related to developing and stockpiling antiviral drugs. GAO Report [cited 2015 Mar 30]. http:\/\/www.gao.gov\/assets\/330\/320181.html"},{"key":"key-10.3201\/eid2206.151037-201605091329-R8","unstructured":"World Health Organization (WHO). Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003\u20132015 [cited 2015 Mar 30]. http:\/\/www.who.int\/influenza\/human_animal_interface\/EN_GIP_20150303cumulativeNumberH5N1cases.pdf?ua=1."},{"key":"key-10.3201\/eid2206.151037-201605091329-R9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/phar.1656","article-title":"Influenza antiviral expenditures and outpatient prescriptions in the United States, 2003\u20132012.","volume":"35","author":"Suda","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"2","key":"key-10.3201\/eid2206.151037-201605091329-R10","first-page":"CD001265","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults.","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.3201\/eid2206.151037-201605091329-R11","doi-asserted-by":"publisher","first-page":"b5164","DOI":"10.1136\/bmj.b5164","article-title":"Neuraminidase inhibitors\u2014the story behind the Cochrane review.","volume":"339","author":"Doshi","year":"2009","journal-title":"BMJ"},{"key":"key-10.3201\/eid2206.151037-201605091329-R12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(06)67970-1","article-title":"Antivirals for influenza in healthy adults: systematic review.","volume":"367","author":"Jefferson","year":"2006","journal-title":"Lancet"},{"key":"key-10.3201\/eid2206.151037-201605091329-R13","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0140-6736(15)60074-5","article-title":"Influenza: the rational use of oseltamivir.","volume":"385","author":"Kelly","year":"2015","journal-title":"Lancet"},{"key":"key-10.3201\/eid2206.151037-201605091329-R14","doi-asserted-by":"crossref","unstructured":"Cressey D. Analysis of trial data revives flu-drug row. Nature. 2015 Jan 30. [cited 2016 Feb 2] http:\/\/www.nature.com\/news\/analysis-of-trial-data-revives-flu-drug-row-1.16820","DOI":"10.1038\/nature.2015.16820"},{"key":"key-10.3201\/eid2206.151037-201605091329-R15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1136\/thx.2009.130799","article-title":"Outcomes of adults hospitalised with severe influenza.","volume":"65","author":"Lee","year":"2010","journal-title":"Thorax"},{"key":"key-10.3201\/eid2206.151037-201605091329-R16","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/jac\/dkr089","article-title":"Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study.","volume":"66","author":"Hiba","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2206.151037-201605091329-R17","doi-asserted-by":"publisher","first-page":"g2228","DOI":"10.1136\/bmj.g2228","article-title":"Study claiming Tamiflu saved lives was based on \u201cflawed\u201d analysis.","volume":"348","author":"Kmietowicz","year":"2014","journal-title":"BMJ"},{"key":"key-10.3201\/eid2206.151037-201605091329-R18","doi-asserted-by":"publisher","first-page":"g2935","DOI":"10.1136\/bmj.g2935","article-title":"Principal author of PRIDE study responds to news story in the BMJ claiming that the study was based on \u201cflawed\u201d analysis.","volume":"348","author":"Nguyen-Van-Tam","year":"2014","journal-title":"BMJ"},{"key":"key-10.3201\/eid2206.151037-201605091329-R19","doi-asserted-by":"crossref","unstructured":"Antes G, Meerpohl JJ. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality. Lancet Respir Med. 2014;2:e10.","DOI":"10.1016\/S2213-2600(14)70127-4"},{"key":"key-10.3201\/eid2206.151037-201605091329-R20","doi-asserted-by":"crossref","unstructured":"Leonardi-Bee J, Venkatesan S, Muthuri SG, Nguyen-Van-Tam JS, Myles PR. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality. Lancet Respir Med. 2014;2:e10\u20132.","DOI":"10.1016\/S2213-2600(14)70137-7"},{"key":"key-10.3201\/eid2206.151037-201605091329-R21","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12363","article-title":"Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an IPD meta-analysis.","volume":"Nov 25","author":"Muthuri","year":"2015","journal-title":"Influenza Other Respi Viruses"},{"key":"key-10.3201\/eid2206.151037-201605091329-R22","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1086\/656316","article-title":"Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a global patient registry.","volume":"202","author":"Adisasmito","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2206.151037-201605091329-R23","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1086\/523584","article-title":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.","volume":"45","author":"McGeer","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2206.151037-201605091329-R24","unstructured":"Nordstrom BL, Zhu S, Smith JR. Reduction of influenza complications following oseltamivir use. Abstract 937. In: Proceedings and abstracts of the Second European Influenza Conference (St. Julian\u2019s, Malta). St. Julian\u2019s (Malta): European Scientific Working Group on Influenza; 2005."},{"key":"key-10.3201\/eid2206.151037-201605091329-R25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7524.1041","article-title":"The evidence of oseltamivir (Tamiflu) in reducing influenza mortality; a response to \u2018Experts question wisdom of stockpiling oseltamivir.\u2019","volume":"331","author":"Sprenger","year":"2015","journal-title":"BMJ"},{"key":"key-10.3201\/eid2206.151037-201605091329-R26","first-page":"15","article-title":"Influenza virus load in hospitalised patients.","volume":"19","author":"Lee","year":"2013","journal-title":"Hong Kong Med J"},{"key":"key-10.3201\/eid2206.151037-201605091329-R27","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.","volume":"12","author":"de Jong","year":"2006","journal-title":"Nat Med"},{"key":"key-10.3201\/eid2206.151037-201605091329-R28","doi-asserted-by":"publisher","first-page":"e26050","DOI":"10.1371\/journal.pone.0026050","article-title":"Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults.","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid2206.151037-201605091329-R29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1086\/650581","article-title":"Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection.","volume":"50","author":"To","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2206.151037-201605091329-R30","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.","volume":"282","author":"Hayden","year":"1999","journal-title":"JAMA"},{"key":"key-10.3201\/eid2206.151037-201605091329-R31","doi-asserted-by":"publisher","first-page":"e0118780","DOI":"10.1371\/journal.pone.0118780","article-title":"A novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activity.","volume":"10","author":"Oh","year":"2015","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid2206.151037-201605091329-R32","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/jac\/dkr090","article-title":"Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life.","volume":"66","author":"Kumar","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2206.151037-201605091329-R33","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jinf.2011.06.008","article-title":"Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children.","volume":"63","author":"Sugaya","year":"2011","journal-title":"J Infect"},{"key":"key-10.3201\/eid2206.151037-201605091329-R34","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(09)61853-5","article-title":"Pregnancy and H1N1 infection.","volume":"374","author":"Burioni","year":"2009","journal-title":"Lancet"},{"key":"key-10.3201\/eid2206.151037-201605091329-R35","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1447-0756.2011.01812.x","article-title":"Review of the pandemic (H1N1) 2009 among pregnant Japanese women.","volume":"38","author":"Nakai","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"key":"key-10.3201\/eid2206.151037-201605091329-R36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2471\/BLT.11.101733","article-title":"Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico.","volume":"90","author":"Guti\u00e9rrez-Mendoza","year":"2012","journal-title":"Bull World Health Organ"},{"key":"key-10.3201\/eid2206.151037-201605091329-R37","unstructured":"The Academy of Medical Sciences\/Wellcome Trust. Use of neuraminidase inhibitors in influenza [cited 2015 Dec 15]. http:\/\/www.wellcome.ac.uk\/stellent\/groups\/corporatesite\/@policy_communications\/documents\/web_document\/wtp059874.pdf."},{"key":"key-10.3201\/eid2206.151037-201605091329-R38","doi-asserted-by":"publisher","first-page":"f3039","DOI":"10.1136\/bmj.f3039","article-title":"Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial.","volume":"346","author":"South East Asia Infectious Disease Clinical Research Network","year":"2013","journal-title":"BMJ"},{"key":"key-10.3201\/eid2206.151037-201605091329-R39","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cmi.2014.11.020","article-title":"Neuraminidase inhibitors: who, when, where?","volume":"21","author":"Nguyen-Van-Tam","year":"2015","journal-title":"Clin Microbiol Infect"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/22\/6\/15-1037_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:26:47Z","timestamp":1732922807000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/22\/6\/15-1037_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2206.151037","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}